EyePoint Pharmaceuticals Inc. buy Robert W. Baird
Start price
11.11.24
/
50%
€10.87
Target price
11.11.25
€30.99
Performance (%)
-8.27%
End price
12.11.25
€9.97
Summary
This prediction ended on 12.11.25 with a price of €9.97. With a performance of -8.27%, the BUY prediction for EyePoint Pharmaceuticals Inc. by Robert_W__Baird closed slightly in the red. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -13.091% | -13.091% | 53.354% |
| iShares Core DAX® | -0.559% | 0.738% | 14.807% |
| iShares Nasdaq 100 | -0.566% | -0.324% | 3.991% |
| iShares Nikkei 225® | 1.073% | 5.624% | 19.546% |
| iShares S&P 500 | 0.868% | 0.030% | 1.475% |
Comments by Robert_W__Baird for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at Robert W. Baird from $38.00 to $33.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Robert_W__Baird for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.75
08.05.24
08.05.24
€35.34
08.05.25
08.05.25
-48.52%
09.05.25
09.05.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.40
20.04.23
20.04.23
-
20.04.24
20.04.24
205.00%
21.04.24
21.04.24